TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

MediciNova, Inc. (NASDAQ: MNOV) Investor Investigation Over Potential Securities Laws Violations Announced

  • Investors who purchased shares of MediciNova, Inc. (NASDAQ: MNOV), have certain options and should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
MediciNova, Inc.
Security
NASDAQ: MNOV

Summary

An investigation on behalf of investors of MediciNova, Inc. (NASDAQ: MNOV)) shares over potential securities laws violations by MediciNova, Inc and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of MediciNova, Inc. (NASDAQ: MNOV) concerning whether a series of statements by MediciNova, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

La Jolla, CA based MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. Shares of MediciNova, Inc. (NASDAQ: MNOV) declined from as high as $13.00 per share on May 16, 2019 to as low as $10.29 per share on May 20, 2019.

Start Monitoring Your Investments